QQ客服 官方微博 反馈留言

浏览/检索结果: 共9条，第1-9条 帮助 限定条件 专题：复旦大学上海医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文 作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang 收藏  |  浏览/下载：45/0  |  提交时间：2019/12/05 Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China 会议论文 作者:  Wei, Lai;  Xu, Xiaoyun;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Jifang 收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05 The age variation of HER2 immunohistochemistry positive rate in gastric cancer 会议论文 作者:  Qin, Yejun;  Liu, Jianping;  Li, Daiqiang;  Wang, Guoping;  Nie, Xiu 收藏  |  浏览/下载：39/0  |  提交时间：2019/12/05 The age variation of HER2 immunohistochemistry positive rate in gastric cancer 会议论文 作者:  Xi, Yangfeng;  Xu, Chen;  Liu, Yiqiang;  Yan, Xiaochu;  Huang, Chuansheng 收藏  |  浏览/下载：43/0  |  提交时间：2019/12/05 Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study 期刊论文 LANCET DIABETES & ENDOCRINOLOGY, 2018, 卷号: 6, 期号: 8 作者:  Zhu, Dalong;  Gan, Shenglian;  Liu, Yu;  Ma, Jianhua;  Dong, Xiaolin 收藏  |  浏览/下载：27/0  |  提交时间：2019/12/05 Pharmacodynamic subgroup analysis of glucose kinase activator (GKA) after 12 weeks of treatment with HMS5552 in T2DM patients in China 会议论文 作者:  Zhu, Dalong;  Gan, Shenglian;  Liu, Yu;  Ma, Jianhua;  Dong, Xiaolin 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/05 A RASSF1A 133 single-nucleotide polymorphism is associated with increased susceptibility and unfavorable prognosis in non-small cell lung cancer 期刊论文 INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 卷号: 10, 期号: 7 作者:  Wang, An;  Hou, Likun;  Huang, Dayu;  Zhang, Huijun;  Wang, Shaohua 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05 RASSF1A SNP  prognosis  tumor-suppressor gene (TSG)  NSCLC  EGFR mutation   Serum miRNAs as predictive and preventive biomarker for pre-clinical hepatocellular carcinoma 期刊论文 CANCER LETTERS, 2016, 卷号: 373, 期号: 2 作者:  Li, Liang;  Chen, Jianguo;  Chen, Xin;  Tang, Jing;  Guo, Huan 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05 Hepatocellular carcinoma  Circulating miRNAs  Biomarker  Prediction  Prevention   Quality of Life in Patients with Irritable Bowel Syndrome (IBS), Assessed Using the IBS-Quality of Life (IBS-QOL) Measure After 4 and 8 Weeks of Treatment with Mebeverine Hydrochloride or Pinaverium Bromide: Results of an International Prospective Observational Cohort Study in Poland, Egypt, Mexico and China 期刊论文 CLINICAL DRUG INVESTIGATION, 2014, 卷号: 34, 期号: 11 作者:  Hou, Xiaohua;  Chen, Shengliang;  Zhang, Yali;  Sha, Weihong;  Yu, Xiaofeng 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/19